Weiss Ratings Reaffirms "Hold (C)" Rating for Colgate-Palmolive (NYSE:CL)

Key Points

• Weiss Ratings has reaffirmed a "Hold (C)" rating for Colgate-Palmolive (NYSE:CL), while various analysts have given mixed ratings ranging from "Buy" to "Underweight".
• The stock is currently trading at $77.96, down 1.5%, with a market cap of $63.01 billion and a consensus target price of $93.23.
• Colgate-Palmolive reported a quarterly EPS of $0.92, exceeding consensus estimates, and noted a 1.0% year-over-year revenue increase to $5.11 billion.

Colgate-Palmolive (NYSE:CL - Get Free Report)'s stock had its "hold (c)" rating restated by equities research analysts at Weiss Ratings in a report released on Wednesday,Weiss Ratings reports.

A number of other equities research analysts have also commented on the stock. Piper Sandler began coverage on shares of Colgate-Palmolive in a report on Friday, October 3rd. They set a "neutral" rating and a $84.00 price target for the company. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an "underweight" rating for the company in a report on Thursday, September 25th. UBS Group lowered their price target on Colgate-Palmolive from $99.00 to $92.00 and set a "buy" rating for the company in a research report on Wednesday. The Goldman Sachs Group decreased their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a "buy" rating for the company in a report on Thursday, October 2nd. Finally, Morgan Stanley dropped their price target on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Eight investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, Colgate-Palmolive presently has a consensus rating of "Moderate Buy" and a consensus target price of $93.23.

Colgate-Palmolive Stock Down 1.5%

NYSE:CL traded down $1.15 on Wednesday, hitting $77.96. 5,928,426 shares of the company's stock were exchanged, compared to its average volume of 6,007,081. The company has a market cap of $63.01 billion, a P/E ratio of 21.90, a price-to-earnings-growth ratio of 4.11 and a beta of 0.34. The firm has a 50-day moving average price of $82.79 and a 200-day moving average price of $88.08. Colgate-Palmolive has a 52 week low of $77.09 and a 52 week high of $102.61. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the prior year, the business earned $0.91 EPS. Colgate-Palmolive's quarterly revenue was up 1.0% on a year-over-year basis. As a group, analysts expect that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Institutional Investors Weigh In On Colgate-Palmolive

Several institutional investors have recently bought and sold shares of CL. Westend Capital Management LLC boosted its position in Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company's stock worth $25,000 after purchasing an additional 140 shares during the period. Westside Investment Management Inc. boosted its position in shares of Colgate-Palmolive by 85.5% in the second quarter. Westside Investment Management Inc. now owns 282 shares of the company's stock valued at $26,000 after acquiring an additional 130 shares during the period. Cornerstone Planning Group LLC boosted its position in shares of Colgate-Palmolive by 1,913.3% in the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company's stock valued at $28,000 after acquiring an additional 287 shares during the period. Saudi Central Bank bought a new stake in shares of Colgate-Palmolive in the first quarter valued at approximately $29,000. Finally, Vermillion & White Wealth Management Group LLC boosted its position in shares of Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company's stock valued at $30,000 after acquiring an additional 155 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.